ITEM 3.02. UNREGISTERED SALES OF EQUITY SECURITIES

On July 30, 2019, Green Vision Biotechnology Corp. (the "Company") cancelled 89,000,000 shares of common stock, par value $.001 per share, and re-issued them to Able Lead Holdings Limited. The issuance was done pursuant to Section 4(a)(2) of the Securities Act of 1933. as it was a non-public offering.

On May 12, 2017, the Company placed the 89,000,000 shares into escrow with Booth Udall Fuller PLC, pending repayment of a loan and discharge of shares of Lutu International by Able Lead Holdings Limited. Full repayment of such was made on February 27, 2019. Therefore, the 89,000,000 shares were returned from escrow and cancelled, Then they were re-issued to Able Lead Holdings Limited.

2

© Edgar Online, source Glimpses